A nurse is preparing to administer medications to a hospitalized patient who has been taking lithium (Lithobid) for 3 days. The patient is complaining of mild nausea and abdominal bloating. The patient's lithium level is 0.8 mEq/L. What will the nurse do?

Acute changes in mental status accompanied by autonomic instability and neuromuscular abnormalities after initiation of serotonergic medications suggest a life-threatening condition, serotonin toxicity. Serotonin syndrome occurs due to excessive serotonergic activity in the central nervous system, often shortly after starting or increasing doses of SSRIs. Clinical features include agitation, confusion, hyperthermia, tremors, muscle rigidity, and autonomic dysregulation such as diaphoresis. Rapid recognition and immediate discontinuation of the causative agent are critical to prevent progression to severe toxicity or death.

Rationale:
A. Adding an MAOI is dangerous and would significantly worsen the condition. Monoamine oxidase inhibitors further increase serotonin levels and can precipitate severe, potentially fatal serotonin toxicity when combined with SSRIs. This contradicts safe management principles and would intensify symptoms such as hyperthermia, rigidity, and autonomic instability.

B. Decreasing the dose of fluoxetine is inappropriate in an acute toxic reaction. Serotonin syndrome is not dose-managed but requires immediate cessation of the offending agent. Dose reduction would still allow ongoing serotonergic excess and could delay critical intervention, increasing the risk of complications such as seizures or organ failure.

C. An allergic reaction is unlikely because the symptoms described are not consistent with histamine-mediated hypersensitivity. There is no evidence of urticaria, airway swelling, or anaphylaxis. Instead, the combination of agitation, tremor, hyperreflexia, and muscle spasms strongly indicates a toxic serotonergic state rather than an immunologic reaction.

D. Immediate discontinuation of Fluoxetine is the priority intervention in serotonin syndrome. Removing the serotonergic agent stops further accumulation of serotonin activity in the central nervous system. Supportive care, sedation, and close monitoring are also required to stabilize autonomic and neuromuscular symptoms and prevent progression to severe complications.

Headache disorders vary in pathophysiology and treatment approaches, with preventive therapy used to reduce attack frequency and severity in chronic or recurrent conditions. Cluster headache is a severe unilateral headache disorder characterized by cyclical “cluster” periods of intense periorbital pain and autonomic symptoms such as lacrimation and nasal congestion. While first-line prevention includes agents like verapamil, lithium is sometimes used as a second-line option. It is particularly considered in chronic or refractory cases where standard therapies are insufficient.

Rationale:
A. Stress headache is not a formal medical classification but is often used interchangeably with tension-type headache. These headaches are typically managed with simple analgesics and stress reduction techniques rather than mood stabilizers like lithium. Lithium has no role in the prophylaxis of stress-related headache patterns.

B. Tension-type headaches are the most common primary headache disorder and are usually managed with NSAIDs, stress management, and sometimes tricyclic antidepressants. Lithium is not indicated for prevention or treatment of tension headaches and does not target their underlying muscle tension or stress-related mechanisms.

C. Migraine headaches are primarily prevented using medications such as beta-blockers, anticonvulsants, and tricyclic antidepressants. While lithium has been studied in refractory cases, it is not considered a standard or second-line prophylactic agent for migraines. Its use in migraine prevention is limited and uncommon in clinical practice.

D. Cluster headache is the correct answer because lithium is used as a second-line prophylactic treatment, especially in chronic cluster headache when first-line agents like verapamil are ineffective or contraindicated. Lithium helps regulate circadian rhythms and neurotransmitter activity involved in cluster headache cycles. It is particularly useful in preventing recurrent cluster periods in resistant cases.